|
End-of-day quote
Shenzhen S.E.
2026-09-18
|
5-day change | 1st Jan Change | ||
| 8.410 CNY | +1.82% |
|
+2.31% | -20.51% |
| Market Cap | 4.05B 604M 527M 498M 452M 847M 58B 850M 5.96B 2.3B 29.49B 2.27B 2.22B 94.88B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.51B 374M 326M 308M 280M 524M 35.92B 527M 3.69B 1.42B 18.26B 1.41B 1.37B 58.76B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
41.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | +1.82% | ||
| 1 week | +2.31% | ||
| Current month | -3.33% | ||
| 1 month | -12.58% | ||
| 3 months | +3.19% | ||
| 6 months | -22.70% | ||
| Current year | -20.51% |
| 1 week | 8.06 |  | 8.56 |
| 1 month | 8.06 | | 10.24 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 13.8 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.82% | +2.31% | -30.38% | -26.03% | 604M | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.21% | +2.99% | +19.69% | +38.21% | 360.23B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.83% | +61.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 62.14M 54.19M 51.17M 46.46M 87.06M 5.96B 87.42M 613M 237M 3.03B 233M 228M 9.75B | 405M 60.39M 52.66M 49.72M 45.15M 84.6M 5.79B 84.95M 596M 230M 2.95B 227M 222M 9.48B |
| Net income | -68.85M -10.27M -8.96M -8.46M -7.68M -14.39M -986M -14.45M -101M -39.1M -501M -38.59M -37.74M -1.61B | 14.57M 2.17M 1.9M 1.79M 1.63M 3.05M 209M 3.06M 21.44M 8.27M 106M 8.17M 7.99M 341M |
| Net Debt | -1.57B -235M -204M -193M -175M -329M -22.5B -330M -2.31B -893M -11.44B -881M -861M -36.81B | -1.54B -230M -201M -189M -172M -322M -22.08B -324M -2.27B -876M -11.23B -864M -845M -36.12B |
Employees
489
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | CN¥8.410 | +1.82% | 4,551,530 |
| 26-09-17 | CN¥8.260 | +0.85% | 3,246,300 |
| 26-09-16 | CN¥8.190 | +0.74% | 3,348,850 |
| 26-09-15 | CN¥8.130 | -2.75% | 3,073,300 |
| 26-09-14 | CN¥8.360 | +1.70% | 3,596,400 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
